Dublin, July 24, 2024 (GLOBE NEWSWIRE) -- The "Global Coronary Stents Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Global Coronary Stents Market ...
Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.
WASHINGTON, DC—Coronary stent infections are highly fatal and represent an understudied complication following PCI, a new analysis highlights. “Several important questions about coronary stent ...
Bollywood Filmmaker Kuku Kohli died on Tuesday, August 25, at Kokilaben Dhirubhai Ambani Hospital in Mumbai, two days after being admitted following a heart at ...
The recent approval by the US Food and Drug Administration (FDA) of the Absorb GT1 bioresorbable vascular scaffold (BVS) system (Abbott Vascular) got me thinking about a modern-day medical problem: ...
Cordis, a global leader in interventional cardiovascular and endovascular technologies, today announced that the U.S. Food and Drug Administration (FDA) has approved the SELUTION SLR™ (Sustained Limus ...
(Medical Xpress)—Who should get stents, the tiny metal tubes designed to keep once-clogged coronary arteries open? Someone who is having a heart attack certainly should, and the life-prolonging ...
XIENCE Xpedition™ 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents Has the Potential to Reduce Overall Procedural Costs Very Long Lesions Most Often Seen in ...
The world's first drug-eluting bioresorbable plastic vascular scaffold (BVS) is now widely available across Europe and parts of Asia Pacific and Latin America. The Absorb BVS from Abbott (Abbott Park, ...
"Coronary stents do not improve long-term survival, study finds." ScienceDaily. www.sciencedaily.com / releases / 2004 / 11 / 041108013032.htm (accessed September 30, 2026).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results